TF TAVI

DEVICE2 trials

Sponsors

Institut für Pharmakologie und Präventive Medizin, Fundación EPIC

Conditions

Aortic StenosisAortic Valve DiseaseAortic Valve StenosisHeart Valve Diseases

Unknown Phase

Feasibility And Safety of Early Discharge After Transfemoral Transcatheter Aortic Valve Implantation

CompletedNCT02404467

Institut für Pharmakologie und Präventive MedizinAortic Stenosis

Start: 2015-01-31End: 2019-07-31Updated: 2020-10-23

Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation

Active, not recruitingNCT05758909

Fundación EPICAortic Valve Disease, Aortic Valve Stenosis, Heart Valve Diseases

Start: 2023-04-04End: 2026-12-01Target: 585Updated: 2025-12-19

Related Papers

Prespecified Risk Criteria Facilitate Adequate Discharge and Long‐Term Outcomes After Transfemoral Transcatheter Aortic Valve Implantation

Journal of the American Heart Association2020-07-2512 citations

Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial

EuroIntervention2019-06-01109 citations

Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation - rationale and design of the FAST-TAVI registry.

2017-10-1017 citations